2012 | 2011 | 2010
WHPA calls for applications for Small Grants against counterfeits
WHPA has launched the “WHPA campaign on combating counterfeit medical products Small Grants 2013/2014”.
WHPA is seeking proposals from WHPA Member Organizations and WHPA-related student member organizations on innovative approaches to target the following interventions:
- Implementation of the respective regional “WHPA Call to Action” in their countries
- Improved collaboration among health professionals and patient organizations through establishment of inter-professional committees to combat counterfeit medical products in their countries
- Advocacy activities targeted at health decision makers and other key stakeholders
- Communication campaigns to encourage behavioural change among patients and public to only buy medical products from known and reliable sources.
Each application should be made by at least two associations of different health professions in the same country. Proposals that include collaborations with patients’ organizations are strongly encouraged.
Up to 6 proposals will be funded for WHPA Member organizations, each of the value 6,000 USD.
Up to 5 proposals will be funded for WHPA-related student Member organizations, each of the value 2,500 USD.
The deadline for application using the provided form is 15th November 2012.
For more information about the Small Grants 2013/2014, please contact Luc Besancon (
) and the WHPA Secretariat at
WHPA Health Professions present SSFFC intervention at World Health Assembly
WHPA, speaking for 26 million health professionals, called for the proposed new Member State mechanism against Substandard/spurious/falsely-labelled/falsified/counterfeit medical products (SSFFC) to be open to civil society and voiced its support of the new mechanism.
See full text WHPA WHA intervention
WHPA urges international treaty and civil society expertise to fight falsified and counterfeit medical products
At the 130th Executive Board of the World Health Organization in Geneva, the International Pharmaceutical Federation FIP, on behalf of WHPÄ, presented an intervention which called for.an international treaty against counterfeits as today it is not a crime under international law to trade falsified medicines. The intervention also called for an objective to ensure adequate funding to implement the treaty to be included in the terms of reference for a new Member State mechanism to combat this dangerous public health and patient safety issue. In addition, Member States, via the new mecnahism, were urged to be open to the voice of civil society as emerging channels for SSFFC medicines, like the Internet, require additional expertise.
(See full text here)
Related WHO documentation:
EB130.R13 Resolution: Substandard/spurious/falsely-labelled/falsified/counterfeit medical products
EB130/22 Add.1 Report on financial and administrative implications for the Secretariat of resolutions proposed for adoption by the Executive Board or Health Assembly
Joint WHPA / Central European Health Professions initiative for safe medicines
Under the banner of the WHPA “Be Aware, Take Action” campaign, the WHPA Central Europe regional workshop, held on 21 November in Prague, tackled the grave problem of falsified medical products worldwide. Health professionals united to adopt the WHPA Prague Call to Action and urged governments to ramp up fight against falsified medicines.
WHPA Prague Call to Action
WHPA Prague workshop programme
Update from 2011 FIP Congress in Hyderabad, India, about combatting falsified and counterfeit medicines See article in International Pharmacy Journal
Health professionals unite in WHPA Taipei Call to Action: First for the Asian region
Urging governments to ramp up the fight against falsified and counterfeit medicines, health professionals in Asia have joined together to endorse the WHPA Taipei Call to Action to reduce the harmful impact of falsified and counterfeit medical products on patients and the public.
See Media Release Traditional Chinese
Health professionals meet to fight falsified and counterfeit medical products
In a first for the Asian region, national health professions organisations (dentistry, medicine, nursing, pharmacy, and physical therapy) and key stakeholders will meet at a dedicated workshop on falsified and counterfeit medical products, to be held on 30 June and 1 July, in Taipei. More
WHPA Counterfeit Campaign Newsletter
View August Newsletter 2010 or Click here for printable PDF version.
WHPA regional initiatives with HCP associations
In the second half of 2010, two ‘Be Aware, Take Action’ regional workshops were conducted for health care professionals (HCPs). The first was held in Costa Rica, on 19 October, and the second in Nigeria, from 22 to 23 November.
Workshop recommendations and outcomes
One very important recommendation from both workshops is the need for collaboration among health professionals at the national level, through the formation of national health professions alliances, so that health professionals can benefit from each other’s core competencies in fighting this menace. More
San José, Costa Rica regional workshop for health professionals
Fifty-three healthcare professional participants from 23 national health professional organisations and two patient groups in nine countries attended this workshop. At this inaugural meeting, the WHPA San José Call to Action was adopted by workshop participants. Follow up actions have since taken place in Costa Rica, El Salvador, the Dominican Republic, Guatemala and Mexico. More than 20,000 HCPs have been reached as a result of this workshop. Full report | versión
Safe Medicines regional workshop in Abuja, Nigeria
More than ninety participants from 30 health professions organisations and four patient groups in 11 countries attended this workshop. This represents a reach to more than 65,000 HCPs in these countries. There was considerable media coverage, the WHPA Abuja Call to Action was adopted and to date, there has been significant follow up activity by workshop participants in their own countries. Follow up actions have taken place in Ethiopia, Liberia, Nigeria, Rwanda, Tanzania and Uganda, and further activities are being planned in other countries who participated in the workshop. Full report
Plans are underway for workshops in the South-East Asia, Western Pacific, Central and Eastern Europe, Latin America and the Eastern Mediterranean regions in 2011 and 2012.
African joint initiative to fight the dangers of counterfeit medicines
Thirty national health professions organisations endorse 'Abuja Call to Action'
In a first for the African continent, health professions organisations (dentistry, medicine, nursing, pharmacy, and physical therapy) and four patient organisations from fourteen countries have discussed and endorsed the WHPA Abuja Call to Action on Counterfeit Medical Products when they met at the first-ever multi-professional workshop on counterfeit medical products in Africa, held 22-23 November, in Abuja, Nigeria. More
COMMUNIQUÉ DE PRESSE | WHPA ABUJA appel à l’action
San José Call to Action: Fight the dangers of medical counterfeits
JOINT INITATIVE BY THE HEALTH PROFESSIONS FROM CENTRAL AMERICA, THE CARIBBEAN, COLOMBIA AND MEXICO
Representatives twenty-three national health professional organizations (dentistry, medicine, nursing, pharmacy, and physical therapy) and patient organizations, from nine countries have joined together in a ‘Call to Action’, to combat the threat to public health and patient safety posed by counterfeit and falsified medical products. More
COMUNICADO DE PRENSA | Llamado a la Acción
|David Benton, CEO of ICN speaking at WHPA workshop on counterfeiting of medical products in San José on 19 October 2010.
WHPA intervenes at 63rd WHA on the subject of counterfeit medical products
The World Health Professions Alliance was present at the 63rd World Health Assembly, held in Geneva from 17-21 May 2010. On the subject of counterfeit medical products, FIP spoke on behalf of the five WHPA member organizations and stressed that all of us have a common goal to protect the well-being of patients in all parts of the world from poor quality, substandard and counterfeit medical products. WHPA remains very strongly supportive of WHO’s role to assume leadership in combating counterfeit medical products based solely on its mandate for public health interests. Full text of the WHPA counterfeit medical products intervention [46 KB]
Release 17 May 2010 World Health Professions Alliance calls for increased action against counterfeits
version française versión
World Health Professions Alliance calls for vigilance in TB treatment non-response : Citing counterfeit or substandard medicines as possible cause
Geneva, 24 March, 2010 - [194 KB]
Counterfeit campaign briefing at regulation conference